Quest Diagnostics Inc Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Quest Diagnostics Inc (DGX) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $20.00 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-02-26
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $20.00M.
- 2024-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $17.00M.
- 2023-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $6.00M.
- 2022-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $9.00M.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2025-12-31 | $20.00M 10-K · filed 2026-02-26 |
| 2024-12-31 | $17.00M 10-K · filed 2026-02-26 |
| 2023-12-31 | $6.00M 10-K · filed 2025-02-20 |
| 2022-12-31 | $9.00M 10-K · filed 2024-02-22 |
| 2021-12-31 | $29.00M 10-K · filed 2023-02-21 |
| 2020-12-31 | $22.00M 10-K · filed 2022-02-28 |
| 2019-12-31 | $35.00M 10-K · filed 2021-02-22 |
| 2019-09-30 | $37.00M 10-Q · filed 2019-10-23 |
| 2019-06-30 | $37.00M 10-Q · filed 2019-07-24 |
| 2019-03-31 | $39.00M 10-Q · filed 2019-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |